Publication: Smart Mesoporous Nanomaterials for Antitumor Therapy
Loading...
Official URL
Full text at PDC
Publication Date
2015-12
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Citations
Exportar
Abstract
The use of nanomaterials for the treatment of solid tumours is receiving increasing attention by the scientific community. Among them, mesoporous silica nanoparticles (MSNs) exhibit unique features that make them suitable nanocarriers to host, transport and protect drug molecules until the target is reached. It is possible to incorporate different targeting ligands to the outermost surface of MSNs to selectively drive the drugs to the tumour tissues. To prevent the premature release of the cargo entrapped in the mesopores, it is feasible to cap the pore entrances using stimuli-responsive nanogates. Therefore, upon exposure to internal (pH, enzymes, glutathione, etc.) or external (temperature, light, magnetic field, etc.) stimuli, the pore opening takes place and the release of the entrapped cargo occurs. These smart MSNs are capable of selectively reaching and accumulating at the target tissue and releasing the entrapped drug in a specific and controlled fashion, constituting a promising alternative to conventional chemotherapy, which is typically associated with undesired side effects. In this review, we overview the recent advances reported by the scientific community in developing MSNs for antitumor therapy. We highlight the possibility to design multifunctional nanosystems using different therapeutic approaches aimed at increasing the efficacy of the antitumor treatment.
Description
RESEARCHER ID M-3378-2014 (María Vallet Regí)
ORCID 0000-0002-6104-4889 (María Vallet Regí)
UCM subjects
Unesco subjects
Keywords
Citation
1. Xia, Y.; Yang, P.; Sun, Y.; Wu, Y.; Mayers, B.; Gates, B.; Yin, Y.; Kim, F.; Yan, H.
One-dimensional nanostructures: Synthesis, characterization, and applications. Adv. Mater. 2003,
15, 353–389.
2. Sanchez, C.; Belleville, P.; Popall, M.; Nicole, L. Applications of advanced hybrid organic-inorganic
nanomaterials: From laboratory to market. Chem. Soc. Rev. 2011, 40, 696–753.
3. Vallet-Regí, M.; Arcos, D. Nanoceramics in Clinical Use: From Materials to Applications,
2nd ed.; Royal Society of Chemistry: Cambridge, UK, 2015.
4. Lanone, S.; Boczkowski, J. Biomedical applications and potential health risks of nanomaterials:
Molecular mechanisms. Curr. Mol. Med. 2006, 6, 651–663.
5. Roduner, E. Size matters: Why nanomaterials are different. Chem. Soc. Rev. 2006, 35, 583–592.
6. Kim, B.Y.S.; Rutka, J.T.; Chan, W.C.W. Nanomedicine. N. Engl. J. Med. 2010, 363, 2434–2443.
7. Shi, J.; Votruba, A.R.; Farokhzad, O.C.; Langer, R. Nanotechnology in drug delivery and tissue
engineering: From discovery to applications. Nano Lett. 2010, 10, 3223–3230.
8. Fernandez-Fernandez, A.; Manchanda, R.; McGoron, A. Theranostic applications of
nanomaterials in cancer: Drug delivery, image-guided therapy, and multifunctional platforms.
Appl. Biochem. Biotechnol. 2011, 165, 1628–1651.
9. Albanese, A.; Tang, P.S.; Chan, W.C.W. The Effect of Nanoparticle Size, Shape, and Surface
Chemistry on Biological Systems. Annu. Rev. Biomed. Eng. 2012, 14, 1–16.
10. Doane, T.L.; Burda, C. The unique role of nanoparticles in nanomedicine: Imaging, drug delivery
and therapy. Chem. Soc. Rev. 2012, 41, 2885–2911.
11. Etheridge, M.L.; Campbell, S.A.; Erdman, A.G.; Haynes, C.L.; Wolf, S.M.; McCullough, J. The
big picture on nanomedicine: The state of investigational and approved nanomedicine products.
Nanomedicine 2013, 9, 1–14.
12. Barreto, J.A.; O’Malley, W.; Kubeil, M.; Graham, B.; Stephan, H.; Spiccia, L. Nanomaterials:
Applications in cancer imaging and therapy. Adv. Mater. 2011, 23, H18–H40.
13. Xie, J.; Liu, G.; Eden, H.S.; Ai, H.; Chen, X. Surface-engineered magnetic nanoparticle
platforms for cancer imaging and therapy. Acc. Chem. Res. 2011, 44, 883–892.
14. Vallet-Regí, M.; Ruiz-Hernandez, E. Bioceramics: From bone regeneration to cancer
nanomedicine. Adv. Mater. 2011, 23, 5177–5218.
15. Baeza, A. Ceramic Nanoparticles for Cancer Treatment. In Bio-Ceramics with Clinical
Applications; Vallet-Regí, M., Ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2014; pp. 421–455.
16. International Agency for Research on Cancer. World Cancer Report; WHO: Geneva,
Switzerland, 2014.
17. Patil, Y.B.; Swaminathan, S.K.; Sadhukha, T.; Ma, L.; Panyam, J. The use of nanoparticle-mediated
targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 2010,
31, 358–365.
18. Misra, R.; Acharya, S.; Sahoo, S.K. Cancer nanotechnology: Application of nanotechnology in
cancer therapy. Drug Discov. Today 2010, 15, 842–850.
19. Wang, X.; Yang, L.; Chen, Z.; Shin, D.M. Application of nanotechnology in cancer therapy and
imaging. CA Cancer J. Clin. 2008, 58, 97–110.
Nanomaterials 2015, 5 1926
20. Andersson, J.; Rosenholm, J.; Areva, S.; Linden, M. Influences of material characteristics on
ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices.
Chem. Mater. 2004, 16, 4160–4167.
21. Scheinberg, D.A.; Villa, C.H.; Escorcia, F.E.; McDevitt, M.R. Conscripts of the infinite armada:
Systemic cancer therapy using nanomaterials. Nat. Rev. Clin. Oncol. 2010, 7, 266–276.
22. Algar, W.R.; Prasuhn, D.E.; Stewart, M.H.; Jennings, T.L.; Blanco-Canosa, J.B.; Dawson, P.E.;
Medintz, I.L. The controlled display of biomolecules on nanoparticles: A challenge suited to
bioorthogonal chemistry. Bioconjug. Chem. 2011, 22, 825–858.
23. Vallet-Regí, M.; Ramila, A.; del Real, R.P.; Perez-Pariente, J. A new property of MCM-41: Drug
delivery system. Chem. Mater. 2001, 13, 308–311.
24. Vallet-Regí, M.; Balas, F.; Arcos, D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed.
2007, 46, 7548–7558.
25. Yang, P.; Quan, Z.; Lu, L.; Huang, S.; Lin, J. Luminescence functionalization of mesoporous
silica with different morphologies and applications as drug delivery systems. Biomaterials 2008,
29, 692–702.
26. Slowing, I.I.; Vivero-Escoto, J.L.; Wu, C.-W.; Lin, V.S.Y. Mesoporous silica nanoparticles as
controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60,
1278–1288.
27. Yang, P.; Quan, Z.; Hou, Z.; Li, C.; Kang, X.; Cheng, Z.; Lin, J. A magnetic, luminescent and
mesoporous core-shell structured composite material as drug carrier. Biomaterials 2009, 30,
4786–4795.
28. Manzano, M.; Colilla, M.; Vallet-Regí, M. Drug delivery from ordered mesoporous matrices.
Expert Opin. Drug Deliv. 2009, 6, 1383–1400.
29. Gai, S.; Yang, P.; Li, C.; Wang, W.; Dai, Y.; Niu, N.; Lin, J. Synthesis of magnetic,
up-conversion luminescent, and mesoporous core-shell-structured nanocomposites as drug
carriers. Adv. Funct. Mater. 2010, 20, 1166–1172.
30. Colilla, M.; González, B.; Vallet-Regí, M. Mesoporous silica nanoparticles for the design of
smart delivery nanodevices. Biomater. Sci. 2013, 1, 114–134.
31. Yang, P.; Gai, S.; Lin, J. Functionalized mesoporous silica materials for controlled drug delivery.
Chem. Soc. Rev. 2012, 41, 3679–3698.
32. Argyo, C.; Weiss, V.; Braeuchle, C.; Bein, T. Multifunctional mesoporous silica nanoparticles as
a universal platform for drug delivery. Chem. Mater. 2014, 26, 435–451.
33. Tang, F.; Li, L.; Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug
delivery. Adv. Mater. 2012, 24, 1504–1534.
34. Li, Z.; Barnes, J.C.; Bosoy, A.; Stoddart, J.F.; Zink, J.I. Mesoporous silica nanoparticles in
biomedical applications. Chem. Soc. Rev. 2012, 41, 2590–2605.
35. Baeza, A.; Colilla, M.; Vallet-Regí, M. Advances in mesoporous silica nanoparticles for targeted
stimuli-responsive drug delivery. Expert Opin. Drug Deliv. 2014, 12, 319–337.
36. Colilla, M.; Baeza, A.; Vallet-Regí, M. Mesoporous Silica Nanoparticles for Drug Delivery and
Controlled Release Applications. In The Sol-Gel Handbook; Levy, D., Zayat, M., Eds.;
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2015; Volume 3, pp. 1309–1344.
Nanomaterials 2015, 5 1927
37. Colilla, M.; Vallet-Regí, M. Responsive Mesoporous Silica Nanoparticles for Targeted Drug
Delivery. In Chemoresponsive Materials: Stimulation by Chemical and Biological Signals;
Schneider, H.J., Ed.; Royal Society of Chemistry: Cambridge, UK, 2015; pp. 136–166.
38. Vallet-Regí, M.; Manzano, M.; Colilla, M. Biomedical Applications of Mesoporous Ceramics:
Drug Delivery, Smart Materials and Bone Tissue Engineering; CRC Press, Taylor & Francis
Group: Boca Raton, FL, USA, 2012.
39. Martínez, Á.; Fuentes-Paniagua, E.; Baeza, A.; Sánchez-Nieves, J.; Cicuéndez, M.; Gómez, R.;
de la Mata, F.J.; González, B.; Vallet-Regí, M. Mesoporous silica nanoparticles decorated with
carbosilane dendrons as new non-viral oligonucleotide delivery carriers. Chemistry 2015, 21,
15651–15666.
40. Colilla, M.; Vallet-Regí, M. Smart Drug Delivery from Silica Nanoparticles. In Smart Materials
for Drug Delivery; Alvarez-Lorenzo, C.; Concheiro, A., Eds.; Royal Society of Chemistry:
Cambridge, UK, 2013; Volume 2, pp. 63–89.
41. Stöber, W.; Fink, A.; Bohn, E. Controlled growth of monodisperse silica spheres in the micron
size range. J. Colloid Interface Sci. 1968, 26, 62–69.
42. Colilla, M. Silica-based Ceramics: Mesoporous Silica. In Bio-Ceramics with Clinical
Applications; Vallet-Regí, M., Ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2014; pp. 109–151.
43. Muñoz, B.; Rámila, A.; Pérez-Pariente, J.; Díaz, I.; Vallet-Regí, M. MCM-41 Organic
modification as drug delivery rate regulator. Chem. Mater. 2003, 15, 500–503.
44. Hoffmann, F.; Cornelius, M.; Morell, J.; Froeba, M. Silica-based mesoporous organic-inorganic
hybrid materials. Angew. Chem. Int. Ed. 2006, 45, 3216–3251.
45. Trewyn, B.G.; Slowing, I.I.; Giri, S.; Chen, H.-T.; Lin, V.S.Y. Synthesis and functionalization of
a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled
release. Acc. Chem. Res. 2007, 40, 846–853.
46. Vallet-Regí, M.; Colilla, M.; González, B. Medical applications of organic-inorganic hybrid
materials within the field of silica-based bioceramics. Chem. Soc. Rev. 2011, 40, 596–607.
47. Grün, M.; Lauer, I.; Unger, K.K. The synthesis of micrometer- and submicrometer-size spheres
of ordered mesoporous oxide MCM-41. Adv. Mater. 1997, 9, 254–257.
48. Lu, Y.F.; Fan, H.Y.; Stump, A.; Ward, T.L.; Rieker, T.; Brinker, C.J. Aerosol-assisted self-assembly
of mesostructured spherical nanoparticles. Nature 1999, 398, 223–226.
49. Brinker, C.J.; Lu, Y.F.; Sellinger, A.; Fan, H.Y. Evaporation-induced self-assembly: Nanostructures
made easy. Adv. Mater. 1999, 11, 579–585.
50. Arcos, D.; López-Noriega, A.; Ruiz-Hernández, E. Ordered mesoporous microspheres for bone
grafting and drug delivery. Chem. Mater. 2009, 21, 1000–1009.
51. Colilla, M.; Manzano, M.; Izquierdo-Barba, I.; Vallet-Regí, M.; Boissiére, C.; Sanchez, C.
Advanced drug delivery vectors with tailored surface properties made of mesoporous binary
oxides submicronic spheres. Chem. Mater. 2010, 22, 1821–1830.
52. Boissiére, C.; Grosso, D.; Chaumonnot, A.; Nicole, L.; Sanchez, C. Aerosol route to functional
nanostructured inorganic and hybrid porous materials. Adv. Mater. 2011, 23, 599–623.
53. Kresge, C.T.; Leonowicz, M.E.; Roth, W.J.; Vartuli, J.C. Ordered mesoporous molecular sieves
synthesized by a liquid-crystal template mechanism. Nature 1992, 359, 710–712.
Nanomaterials 2015, 5 1928
54. Hoffmann, F.; Fröba, M. Vitalising porous inorganic silica networks with organic functions—PMOs
and related hybrid materials. Chem. Soc. Rev. 2011, 40, 608–620.
55. Liong, M.; Angelos, S.; Choi, E.F.; Zink, J.I. Mesostructured multifunctional nanoparticles for
imaging and drug delivery. J. Mater. Chem. 2009, 19, 6251–6257.
56. Lin, Y.S.; Tsai, C.P.; Huang, H.Y.; Kuo, C.T.; Hung, Y.; Huang, D.M.; Chen, Y.C.; Mou, C.Y.
Well-ordered mesoporous silica nanoparticles as cell markers. Chem. Mater. 2005, 17, 4570–4573.
57. Lu, J.; Liong, M.; Sherman, S.; Xia, T.; Kovochich, M.; Nel, A.E.; Zink, J.I.; Tamanoi, F.
Mesoporous silica nanoparticles for cancer therapy: Energy-dependent cellular uptake and
delivery of paclitaxel to cancer cells. Nanobiotechnology 2007, 3, 89–95.
58. Lim, E.-K.; Kim, T.; Paik, S.; Haam, S.; Huh, Y.-M.; Lee, K. Nanomaterials for Theranostics:
Recent Advances and Future Challenges. Chem. Rev. 2015, 115, 327–394.
59. Langer, R. Drug delivery and targeting. Nature 1998, 392, 5–10.
60. Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16–20.
61. Danhier, F.; Feron, O.; Preat, V. To exploit the tumor microenvironment: Passive and active
tumor targeting of nanocarriers for anti-cancer drug delivery. J. Controll. Release 2010, 148,
135–146.
62. Bertrand, N.; Wu, J.; Xu, X.; Kamaly, N.; Farokhzad, O.C. Cancer nanotechnology: The impact
of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014,
66, 2–25.
63. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy.
Mechanism of tumoritropic accumulation of proteins and the antitumor agen smancs. Cancer
Res. 1986, 46, 6387–6392.
64. Davis, M.E.; Chen, Z.; Shin, D.M. Nanoparticle therapeutics: An emerging treatment modality
for cancer. Nat. Rev. Drug Discov. 2008, 7, 771–782.
65. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D.E. Shape effects of
filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2, 249–255.
66. Champion, J.A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci.
USA 2006, 103, 4930–4934.
67. Mitragotri, S. In Drug Delivery, Shape Does Matter. Pharm. Res. 2009, 26, 232–234.
68. Huang, X.; Teng, X.; Chen, D.; Tang, F.; He, J. The effect of the shape of mesoporous silica
nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31, 438–448.
69. Huang, X.; Li, L.; Liu, T.; Hao, N.; Liu, H.; Chen, D.; Tang, F. The shape effect of mesoporous
silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011,
5, 5390–5399.
70. Meng, H.; Xue, M.; Xia, T.; Ji, Z.; Tarn, D.Y.; Zink, J.I.; Nel, A.E. Use of size and a copolymer
design feature to improve the biodistribution and the enhanced permeability and retention effect
of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.
ACS Nano 2011, 5, 4131–4144.
71. Cauda, V.; Argyo, C.; Bein, T. Impact of different PEGylation patterns on the long-term
bio-stability of colloidal mesoporous silica nanoparticles. J. Mater. Chem. 2010, 20, 8693–8699.
72. Karakoti, A.S.; Das, S.; Thevuthasan, S.; Seal, S. PEGylated Inorganic Nanoparticles. Angew.
Chem. Int. Ed. 2011, 50, 1980–1994.
Nanomaterials 2015, 5 1929
73. Cauda, V.; Schlossbauer, A.; Bein, T. Bio-degradation study of colloidal mesoporous silica
nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol).
Microporous Mesoporous Mater. 2010, 132, 60–71.
74. Ferris, D.P.; Lu, J.; Gothard, C.; Yanes, R.; Thomas, C.R.; Olsen, J.-C.; Stoddart, J.F.; Tamanoi, F.;
Zink, J.I. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted
hydrophobic drug delivery to cancer cells. Small 2011, 7, 1816–1826.
75. Fang, W.; Wang, Z.; Zong, S.; Chen, H.; Zhu, D.; Zhong, Y.; Cui, Y. pH-controllable drug
carrier with SERS activity for targeting cancer cells. Biosens. Bioelectron. 2014, 57, 10–15.
76. Martínez-Carmona, M.; Baeza, A.; Rodríguez-Milla, M.A.; García-Castro, J.; Vallet-Regí, M.
Mesoporous silica nanoparticles grafted with a light-responsive protein shell for highly cytotoxic
antitumoral therapy. J. Mater. Chem. B 2015, 3, 5746–5752.
77. Mickler, F.M.; Moeckl, L.; Ruthardt, N.; Ogris, M.; Wagner, E.; Braeuchle, C. Tuning
nanoparticle uptake: Live-cell imaging reveals two distinct endocytosis mechanisms mediated by
natural and artificial EGFR targeting ligand. Nano Lett. 2012, 12, 3417–3423.
78. Rosenholm, J.M.; Meinander, A.; Peuhu, E.; Niemi, R.; Eriksson, J.E.; Sahlgren, C.; Linden, M.
Targeting of porous hybrid silica nanoparticles to Cancer Cells. ACS Nano 2009, 3, 197–206.
79. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S.G.; Nel, A.E.; Tamanoi, F.; Zink, J.I.
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano
2008, 2, 889–896.
80. Lu, J.; Liong, M.; Li, Z.X.; Zink, J.I.; Tamanoi, F. Biocompatibility, biodistribution, and
drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small
2010, 6, 1794–1805.
81. Lu, J.; Li, Z.; Zink, J.I.; Tamanoi, F. In vivo tumor suppression efficacy of mesoporous silica
nanoparticles-based drug-delivery system: Enhanced efficacy by folate modification. Nanomed.
Nanotechnol. Biol. Med. 2012, 8, 212–220.
82. Wang, L.-S.; Wu, L.-C.; Lu, S.-Y.; Chang, L.-L.; Teng, I.T.; Yang, C.-M.; Ho, J.-A.A.
Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug
delivery: Improved water suspensibility and decreased nonspecific protein binding. ACS Nano
2010, 4, 4371–4379.
83. Slowing, I.; Trewyn, B.G.; Lin, V.S.Y. Effect of surface functionalization of MCM-41-type
mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc.
2006, 128, 14792–14793.
84. Porta, F.; Lamers, G.E.M.; Morrhayim, J.; Chatzopoulou, A.; Schaaf, M.; den Dulk, H.;
Backendorf, C.; Zink, J.I.; Kros, A. Folic acid-modified mesoporous silica nanoparticles for
cellular and nuclear targeted drug delivery. Adv. Healthc. Mater. 2013, 2, 281–286.
85. Vivero-Escoto, J.L.; Taylor-Pashow, K.M.L.; Huxford, R.C.; Della Rocca, J.; Okoruwa, C.;
An, H.; Lin, W.; Lin, W. Multifunctional mesoporous silica nanospheres with cleavable Gd(III)
chelates as MRI contrast agents: Synthesis, characterization, target-specificity, and renal
clearance. Small 2011, 7, 3519–3528.
86. Rosenholm, J.M.; Peuhu, E.; Bate-Eya, L.T.; Eriksson, J.E.; Sahlgren, C.; Linden, M.
Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as
drug-delivery vectors. Small 2010, 6, 1234–1241.
Nanomaterials 2015, 5 1930
87. Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear-targeted drug delivery of
TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 2012,
134, 5722–5725.
88. Li, Z.; Dong, K.; Huang, S.; Ju, E.; Liu, Z.; Yin, M.; Ren, J.; Qu, X. A smart nanoassembly for
multistage targeted drug delivery and magnetic resonance imaging. Adv. Funct. Mater. 2014, 24,
3612–3620.
89. Pan, L.; Liu, J.; He, Q.; Wang, L.; Shi, J. Overcoming multidrug resistance of cancer cells by
direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.
Biomaterials 2013, 34, 2719–2730.
90. Wang, Y.; Wang, K.; Zhao, J.; Liu, X.; Bu, J.; Yan, X.; Huang, R. Multifunctional mesoporous
silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of
glioma. J. Am. Chem. Soc. 2013, 135, 4799–4804.
91. Milgroom, A.; Intrator, M.; Madhavan, K.; Mazzaro, L.; Shandas, R.; Liu, B.; Park, D.
Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent. Colloids
Surfaces B 2014, 116, 652–657.
92. Tsai, C.-P.; Chen, C.-Y.; Hung, Y.; Chang, F.-H.; Mou, C.-Y. Monoclonal antibody-functionalized
mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J. Mater.
Chem. 2009, 19, 5737–5743.
93. Deng, Z.; Zhen, Z.; Hu, X.; Wu, S.; Xu, Z.; Chu, P.K. Hollow chitosan-silica nanospheres as
pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 2011, 32, 4976–4986.
94. Cheng, K.; Blumen, S.R.; MacPherson, M.B.; Steinbacher, J.L.; Mossman, B.T.; Landry, C.C.
Enhanced uptake of porous silica microparticles by bifunctional surface modification with a
targeting antibody and a biocompatible polymer. ACS Appl. Mater. Interfaces 2010, 2, 2489–2495.
95. Chen, F.; Hong, H.; Zhang, Y.; Valdovinos, H.F.; Shi, S.; Kwon, G.S.; Theuer, C.P.; Barnhart, T.E.;
Cai, W. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radio
labeled mesoporous silica nanoparticles. ACS Nano 2013, 7, 9027–9039.
96. Villaverde, G.; Baeza, A.; Melen, G.J.; Alfranca, A.; Ramirez, M.; Vallet-Regí, M. A new
targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma.
J. Mater. Chem. B 2015, 3, 4831–4842.
97. Cheng, S.-H.; Lee, C.-H.; Chen, M.-C.; Souris, J.S.; Tseng, F.-G.; Yang, C.-S.; Mou, C.-Y.;
Chen, C.-T.; Lo, L.-W. Tri-functionalization of mesoporous silica nanoparticles for
comprehensive cancer theranostics-the trio of imaging, targeting and therapy. J. Mater. Chem.
2010, 20, 6149–6157.
98. Fang, I.J.; Slowing, I.I.; Wu, K.C.W.; Lin, V.S.Y.; Trewyn, B.G. Ligand conformation dictates
membrane and endosomal trafficking of arginine-glycine-aspartate (RGD)-functionalized
mesoporous silica nanoparticles. Chemistry 2012, 18, 7787–7792.
99. Luo, G.-F.; Chen, W.-H.; Liu, Y.; Zhang, J.; Cheng, S.-X.; Zhuo, R.-X.; Zhang, X.-Z.
Charge-reversal plug gate nanovalves on peptide-functionalized mesoporous silica nanoparticles
for targeted drug delivery. J. Mater. Chem. B 2013, 1, 5723–5732.
100. Zhang, J.; Yuan, Z.-F.; Wang, Y.; Chen, W.-H.; Luo, G.-F.; Cheng, S.-X.; Zhuo, R.-X.; Zhang, X.-Z.
Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug
delivery. J. Am. Chem. Soc. 2013, 135, 5068–5073.
Nanomaterials 2015, 5 1931
101. Xiao, D.; Jia, H.-Z.; Zhang, J.; Liu, C.-W.; Zhuo, R.-X.; Zhang, X.-Z. A dual-responsive mesoporous
silica nanoparticle for tumor-triggered targeting drug delivery. Small 2014, 10, 591–598.
102. He, L.; Huang, Y.; Zhu, H.; Pang, G.; Zheng, W.; Wong, Y.-S.; Chen, T. Cancer-targeted
monodisperse mesoporous silica nanoparticles as carrier of ruthenium polypyridyl complexes to
enhance theranostic effects. Adv. Funct. Mater. 2014, 24, 2754–2763.
103. Yang, H.; Zhao, F.; Li, Y.; Xu, M.; Li, L.; Wu, C.; Miyoshi, H.; Liu, Y. VCAM-1-targeted
core/shell nanoparticles for selective adhesion and delivery to endothelial cells with
lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance
imaging in vitro. Int. J. Nanomed. 2013, 8, 1897–1906.
104. Goel, S.; Chen, F.; Hong, H.; Valdovinos, H.F.; Hernandez, R.; Shi, S.; Barnhart, T.E.; Cai, W.
VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery
System. ACS Appl. Mater. Interfaces 2014, 6, 21677–21685.
105. Xu, S.; Olenyuk, B.Z.; Okamoto, C.K.; Hamm-Alvarez, S.F. Targeting receptor-mediated
endocytotic pathways with nanoparticles: Rationale and advances. Adv. Drug Deliv. Rev. 2013,
65, 121–138.
106. Elnakat, H.; Ratnam, M. Distribution, functionality and gene regulation of folate receptor
isoforms: Implications in targeted therapy. Adv. Drug Deliv. Rev. 2004, 56, 1067–1084.
107. Mendelsohn, J.; Baselga, J. Epidermal growth factor receptor targeting in cancer. Semin. Oncol.
2006, 33, 369–385.
108. Scott, A.M.; Wolchok, J.D.; Old, L.J. Antibody therapy of cancer. Nat. Rev. Cancer 2012, 12,
278–287.
109. Cathcart, J.; Pulkoski-Gross, A.; Cao, J. Targeting matrix metalloproteinases in cancer: Bringing
new life to old ideas. Genes Dis. 2015, 2, 26–34.
110. Gialeli, C.; Theocharis, A.D.; Karamanos, N.K. Roles of matrix metalloproteinases in cancer
progression and their pharmacological targeting. FEBS J. 2011, 278, 16–27.
111. Chen, Y.; Chen, H.; Zeng, D.; Tian, Y.; Chen, F.; Feng, J.; Shi, J. Core/shell structured hollow
mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer
drug delivery. ACS Nano 2010, 4, 6001–6013.
112. Aznar, E.; Mondragon, L.; Ros-Lis, J.V.; Sancenon, F.; Dolores Marcos, M.; Martinez-Manez, R.;
Soto, J.; Perez-Paya, E.; Amoros, P. Finely tuned temperature-controlled cargo release using
paraffin-capped mesoporous silica nanoparticles. Angew. Chem. Int. Ed. 2011, 50, 11172–11175.
113. Jadhav, S.A.; Miletto, I.; Brunella, V.; Berlier, G.; Scalarone, D. Controlled post-synthesis
grafting of thermoresponsive poly(N-isopropylacrylamide) on mesoporous silica nanoparticles.
Polym. Adv. Technol. 2015, 26, 1070–1075.
114. Schlossbauer, A.; Warncke, S.; Gramlich, P.M.E.; Kecht, J.; Manetto, A.; Carell, T.; Bein, T.
A programmable DNA-based molecular valve for colloidal mesoporous silica. Angew. Chem. Int. Ed.
2010, 49, 4734–4737.
115. Martelli, G.; Zope, H.R.; Capell, M.B.; Kros, A. Coiled-coil peptide motifs as thermoresponsive
valves for mesoporous silica nanoparticles. Chem. Commun. 2013, 49, 9932–9934.
116. Zhu, Y.; Liu, H.; Li, F.; Ruan, Q.; Wang, H.; Fujiwara, M.; Wang, L.; Lu, G.Q. Dipolar
molecules as impellers achieving electric-field-stimulated release. J. Am. Chem. Soc. 2010, 132,
1450–1451.
Nanomaterials 2015, 5 1932
117. Ruiz-Hernández, E.; Baeza, A.; Vallet-Regí, M. Smart drug delivery through DNA/magnetic
nanoparticle gates. ACS Nano 2011, 5, 1259–1266.
118. Thomas, C.R.; Ferris, D.P.; Lee, J.-H.; Choi, E.; Cho, M.H.; Kim, E.S.; Stoddart, J.F.; Shin, J.-S.;
Cheon, J.; Zink, J.I. Non-invasive remote-controlled release of drug molecules in vitro using
magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 2010, 132, 10623–10625.
119. Baeza, A.; Guisasola, E.; Ruiz-Hernandez, E.; Vallet-Regí, M. Magnetically triggered multidrug
release by hybrid mesoporous silica nanoparticles. Chem. Mater. 2012, 24, 517–524.
120. Saint-Cricq, P.; Deshayes, S.; Zink, J.I.; Kasko, A.M. Magnetic field activated drug delivery
using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica
nanoparticles. Nanoscale 2015, 7, 13168–13172.
121. Yang, X.; Liu, X.; Liu, Z.; Pu, F.; Ren, J.; Qu, X. Near-infrared light-triggered, targeted drug
delivery to cancer cells by aptamer gated nanovehicles. Adv. Mater. 2012, 24, 2890–2895.
122. Zhu, Y.; Fujiwara, M. Installing dynamic molecular photomechanics in mesopores: A
multifunctional controlled-release nanosystem. Angew. Chem. Int. Ed. 2007, 46, 2241–2244.
123. Ferris, D.P.; Zhao, Y.-L.; Khashab, N.M.; Khatib, H.A.; Stoddart, J.F.; Zink, J.I. Light-operated
mechanized nanoparticles. J. Am. Chem. Soc. 2009, 131, 1686–1688.
124. Liu, R.; Zhang, Y.; Zhao, X.; Agarwal, A.; Mueller, L.J.; Feng, P. pH-responsive nanogated
ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker.
J. Am. Chem. Soc. 2010, 132, 1500–1501.
125. Gan, Q.; Lu, X.; Yuan, Y.; Qian, J.; Zhou, H.; Lu, X.; Shi, J.; Liu, C. A magnetic, reversible
pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Biomaterials 2011, 32, 1932–1942.
126. Xu, C.; Lin, Y.; Wang, J.; Wu, L.; Wei, W.; Ren, J.; Qu, X. Nanoceria-triggered synergetic drug
release based on CeO2-capped mesoporous silica host-guest interactions and switchable
enzymatic activity and cellular effects of CeO2. Adv. Healthc. Mater. 2013, 2, 1591–1599.
127. Feng, W.; Zhou, X.; He, C.; Qiu, K.; Nie, W.; Chen, L.; Wang, H.; Mo, X.; Zhang, Y.
Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug
delivery: Layer thickness-dependent release profiles and biocompatibility. J. Mater. Chem. B
2013, 1, 5886–5898.
128. Meng, H.; Xue, M.; Xia, T.; Zhao, Y.-L.; Tamanoi, F.; Stoddart, J.F.; Zink, J.I.; Nel, A.E.
Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by
pH-sensitive nanovalves. J. Am. Chem. Soc. 2010, 132, 12690–12697.
129. Gao, Y.; Yang, C.; Liu, X.; Ma, R.; Kong, D.; Shi, L. A multifunctional nanocarrier based on
nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery.
Macromol. Biosci. 2012, 12, 251–259.
130. Rim, H.P.; Min, K.H.; Lee, H.J.; Jeong, S.Y.; Lee, S.C. pH-tunable calcium phosphate covered
mesoporous silica nanocontainers for intracellular controlled release of guest drugs. Angew.
Chem. Int. Ed. 2011, 50, 8853–8857.
131. Ma, X.; Nguyen, K.T.; Borah, P.; Ang, C.Y.; Zhao, Y. Functional silica nanoparticles for
redox-triggered drug/ssDNA co-delivery. Adv. Healthc. Mater. 2012, 1, 690–697.
Nanomaterials 2015, 5 1933
132. Zhang, J.; Niemela, M.; Westermarck, J.; Rosenholm, J.M. Mesoporous silica nanoparticles with
redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides.
Dalton Trans. 2014, 43, 4115–4126.
133. Lai, C.-Y.; Trewyn, B.G.; Jeftinija, D.M.; Jeftinija, K.; Xu, S.; Jeftinija, S.; Lin, V.S.Y.
A mesoporous silica nanosphere-based carrier system with chemically removable CdS
nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug
molecules. J. Am. Chem. Soc. 2003, 125, 4451–4459.
134. Nadrah, P.; Porta, F.; Planinsek, O.; Kros, A.; Gaberscek, M. Poly(propylene imine) dendrimer
caps on mesoporous silica nanoparticles for redox-responsive release: Smaller is better. Phys.
Chem. Chem. Phys. 2013, 15, 10740–10748.
135. Agostini, A.; Mondragón, L.; Coll, C.; Aznar, E.; Marcos, M.D.; Martínez-Máñez, R.; Sancenón, F.;
Soto, J.; Pérez-Payá, E.; Amorós, P. Dual enzyme-triggered controlled release on capped
nanometric silica mesoporous supports. ChemistryOpen 2012, 1, 17–20.
136. Van Rijt, S.H.; Bölükbas, D.A.; Argyo, C.; Datz, S.; Lindner, M.; Eickelberg, O.; Königshoff, M.;
Bein, T.; Meiners, S. Protease-mediated release of chemotherapeutics from mesoporous silica
nanoparticles to ex vivo human and mouse lung tumors. ACS Nano 2015, 9, 2377–2389.
137. Singh, N.; Karambelkar, A.; Gu, L.; Lin, K.; Miller, J.S.; Chen, C.S.; Sailor, M.J.; Bhatia, S.N.
Bioresponsive mesoporous silica nanoparticles for triggered drug release. J. Am. Chem. Soc.
2011, 133, 19582–19585.
138. Park, C.; Kim, H.; Kim, S.; Kim, C. Enzyme responsive nanocontainers with cyclodextrin
gatekeepers and synergistic effects in release of guests. J. Am. Chem. Soc. 2009, 131,
16614–16615.
139. Baeza, A.; Guisasola, E.; Torres-Pardo, A.; González-Calbet, J.M.; Melen, G.J.; Ramirez, M.;
Vallet-Regí, M. Hybrid enzyme-polymeric capsules/mesoporous silica nanodevice for in situ
cytotoxic agent generation. Adv. Funct. Mater. 2014, 24, 4625–4633.
140. Mas, N.; Arcos, D.; Polo, L.; Aznar, E.; Sánchez-Salcedo, S.; Sancenón, F.; García, A.;
Marcos, M.D.; Baeza, A.; Vallet-Regí, M.; Martínez-Máñez, R. Towards the development of
smart 3D “gated scaffolds” for on-command delivery. Small 2014, 10, 4859–4864.
141. Aznar, E.; Villalonga, R.; Gimenez, C.; Sancenon, F.; Marcos, M.D.; Martinez-Mañez, R.;
Diez, P.; Pingarron, J.M.; Amoros, P. Glucose-triggered release using enzyme-gated mesoporous
silica nanoparticles. Chem. Commun. 2013, 49, 6391–6393.
142. Climent, E.; Bernardos, A.; Martínez-Máñez, R.; Maquieira, A.; Marcos, M.D.; Pastor-Navarro,
N.; Puchades, R.; Sancenón, F.; Soto, J.; Amorós, P. Controlled delivery systems using
antibody-capped mesoporous nanocontainers. J. Am. Chem. Soc. 2009, 131, 14075–14080.
143. He, X.; Zhao, Y.; He, D.; Wang, K.; Xu, F.; Tang, J. ATP-responsive controlled release system
using aptamer-functionalized mesoporous silica nanoparticles. Langmuir 2012, 28,
12909–12915.
144. Álvarez-Lorenzo, C.; Concheiro, A. From Drug Dosage Forms to Intelligent Drug-delivery
Systems: A Change of Paradigm. In Smart Materials for Drug Delivery; Royal Society of
Chemistry: London, UK, 2013; Volume 1, pp. 1–32.
145. Gustafson, T.P.; Cao, Q.; Wang, S.; Berezin, M.Y. Design of irreversible optical nanothermometers
for thermal ablations. Chem. Commun. 2013, 49, 680–682.
Nanomaterials 2015, 5 1934
146. Nuyken, O.; Dauth, J.; Pekruhn, W. Synthesis and application of thermosensitive microcapsules
containing azo groups. Die Angew. Makromol. Chem. 1991, 187, 207–224.
147. Liechty, W.B.; Kryscio, D.R.; Slaughter, B.V.; Peppas, N.A. Polymers for Drug Delivery
Systems. Annu. Rev. Chem. Biomol. Eng. 2010, 1, 149–173.
148. Gilman, M.; Gilman, S.L. Electrotherapy and the human voice: A literature review of the
historical origins and contemporary applications. J. Voice 2008, 22, 219–231.
149. Gilula, M.F. Cranial electrotherapy stimulation and fibromyalgia. Expert Rev. Med. Devices
2007, 4, 489–495.
150. Ciria, H.C.; Quevedo, M.S.; Cabrales, L.B.; Bruzon, R.P.; Salas, M.F.; Pena, O.G.; González, T.R.;
Lopez, D.S.; Flores, J.M. Antitumor effectiveness of different amounts of electrical charge in
Ehrlich and fibrosarcoma Sa-37 tumors. BMC Cancer 2004, 4, 11.
151. Santini, J.T.; Cima, M.J.; Langer, R. A controlled-release microchip. Nature 1999, 397, 335–338.
152. Kwon, I.C.; Bae, Y.H.; Kim, S.W. Electrically erodible polymer gel for controlled release of
drugs. Nature 1991, 354, 291–293.
153. Ge, J.; Neofytou, E.; Cahill, T.J., III; Beygui, R.E.; Zare, R.N. Drug release from
electric-field-responsive nanoparticles. ACS Nano 2012, 6, 227–233.
154. Ruiz-Hernández, E.; López-Noriega, A.; Arcos, D.; Izquierdo-Barba, I.; Terasaki, O.; Vallet-Regí, M.
Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chem.
Mater. 2007, 19, 3455–3463.
155. Van de Linde, S.; Sauer, M. How to switch a fluorophore: From undesired blinking to controlled
photoswitching. Chem. Soc. Rev. 2014, 43, 1076–1087.
156. Bansal, A.; Zhang, Y. Photocontrolled nanoparticle delivery systems for biomedical applications.
Acc. Chem. Res. 2014, 47, 3052–3060.
157. Lee, E.S.; Gao, Z.; Bae, Y.H. Recent progress in tumor pH targeting nanotechnology.
J. Controll. Release 2008, 132, 164–170.
158. Casey, J.R.; Grinstein, S.; Orlowski, J. Sensors and regulators of intracellular pH. Nat. Rev. Mol.
Cell Biol. 2010, 11, 50–61.
159. Lee, C.-H.; Cheng, S.-H.; Huang, I.P.; Souris, J.S.; Yang, C.-S.; Mou, C.-Y.; Lo, L.-W.
Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of
anticancer chemotherapeutics. Angew. Chem. Int. Ed. 2010, 49, 8214–8219.
160. Lee, J.E.; Lee, D.J.; Lee, N.; Kim, B.H.; Choi, S.H.; Hyeon, T. Multifunctional mesoporous silica
nanocomposite nanoparticles for pH controlled drug release and dual modal imaging. J. Mater.
Chem. 2011, 21, 16869–16872.
161. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive
nano-vehicles as a promising platform for targeted intracellular drug and gene delivery.
J. Controll. Release 2011, 152, 2–12.
162. Kuppusamy, P.; Li, H.; Ilangovan, G.; Cardounel, A.J.; Zweier, J.L.; Yamada, K.; Krishna, M.C.;
Mitchell, J.B. Noninvasive imaging of tumor redox status and its modification by tissue
glutathione levels. Cancer Res. 2002, 62, 307–312.
163. Yuan, L.; Chen, W.; Hu, J.; Zhang, J.Z.; Yang, D. Mechanistic study of the covalent loading of
Paclitaxel via disulfide linkers for controlled drug release. Langmuir 2013, 29, 734–743.
Nanomaterials 2015, 5 1935
164. Mortera, R.; Vivero-Escoto, J.; Slowing, I.I.; Garrone, E.; Onida, B.; Lin, V.S.Y. Cell-induced
intracellular controlled release of membrane impermeable cysteine from a mesoporous silica
nanoparticle-based drug delivery system. Chem. Commun. 2009, 14, 3219–3221.
165. Bareford, L.A.; Swaan, P.W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv.
Rev. 2007, 59, 748–758.
166. Chan, P.; Lovric, J.; Warwicker, J. Subcellular pH and predicted pH-dependent features of
proteins. Proteomics 2006, 6, 3494–3501.
167. Geisow, M.J. Fluorescein conjugates as indicators of subcellular pH-A critical evaluacion.
Exp. Cell Res. 1984, 150, 29–35.
168. De la Rica, R.; Aili, D.; Stevens, M.M. Enzyme-responsive nanoparticles for drug release and
diagnostics. Adv. Drug Deliv. Rev. 2012, 64, 967–978.
169. Fukami, T.; Yokoi, T. The Emerging role of human esterases. Drug Metabol. Pharm. 2012, 27,
466–477.
170. Runquist, E.A.; Havel, R.J. Acid-hydrolases in early and late endosome fractions from rat-liver.
J. Biol. Chem. 1991, 266, 22557–22563.
171. Swarnakar, S.; Paul, S.; Singh, L.P.; Reiter, R.J. Matrix metalloproteinases in health and disease:
Regulation by melatonin. J. Pineal Res. 2011, 50, 8–20.
172. De Melo, M.P.; de Lima, T.M.; Pithon-Curi, T.C.; Curi, R. The mechanism of indole acetic acid
cytotoxicity. Toxicol. Lett. 2004, 148, 103–111.
173. Sun, L.; Zhang, X.; Zheng, C.; Wu, Z.; Li, C. A pH gated, clucose-sensitive nanoparticle based
on worm-like mesoporous silica for controlled insulin release. J. Phys. Chem. B 2013, 117,
3852–3860.
174. Zhao, Z.; Meng, H.; Wang, N.; Donovan, M.J.; Fu, T.; You, M.; Chen, Z.; Zhang, X.; Tan, W.
A Controlled-release nanocarrier with extracellular pH value driven tumor targeting and
translocation for drug delivery. Angew. Chem. Int. Ed. 2013, 52, 7487–7491.
175. Chen, C.; Geng, J.; Pu, F.; Yang, X.; Ren, J.; Qu, X. Polyvalent nucleic acid/mesoporous silica
nanoparticle conjugates: Dual stimuli-responsive vehicles for intracellular drug delivery.
Angew. Chem. Int. Ed. 2011, 50, 882–886.
176. Zhang, X.; Yang, P.; Dai, Y.; Ma, P.A.; Li, X.; Cheng, Z.; Hou, Z.; Kang, X.; Li, C.; Lin, J.
Multifunctional up-converting nanocomposites with smart polymer brushes gated mesopores for
cell imaging and thermo/pH dual-responsive drug controlled release. Adv. Funct. Mater. 2013,
23, 4067–4078.
177. Fang, W.; Yang, J.; Gong, J.; Zheng, N. Photo- and pH-Triggered Release of Anticancer Drugs
from Mesoporous Silica-Coated Pd@Ag Nanoparticles. Adv. Funct. Mater. 2012, 22, 842–848.
178. Angelos, S.; Yang, Y.-W.; Khashab, N.M.; Stoddart, J.F.; Zink, J.I. Dual-controlled
nanoparticles exhibiting AND logic. J. Am. Chem. Soc. 2009, 131, 11344–11346.
179. Yao, X.; Chen, X.; He, C.; Chen, L.; Chen, X. Dual pH-responsive mesoporous silica
nanoparticles for efficient combination of chemotherapy and photodynamic therapy. J. Mater.
Chem. B 2015, 3, 4707–4714.
180. Fu, C.; Liu, T.; Li, L.; Liu, H.; Chen, D.; Tang, F. The absorption, distribution, excretion and
toxicity of mesoporous silica nanoparticles in mice following different exposure routes.
Biomaterials 2013, 34, 2565–2575.
Nanomaterials 2015, 5 1936
181. Lee, S.-F.; Zhu, X.-M.; Wang, Y.-X.J.; Xuan, S.-H.; You, Q.; Chan, W.-H.; Wong, C.-H.; Wang, F.;
Yu, J.C.; Cheng, C.H.K.; et al. Ultrasound, pH, and magnetically responsive crown-ether-coated
core/shell nanoparticles as drug encapsulation and release systems. ACS Appl. Mater. Interfaces
2013, 5, 1566–1574.
182. Chen, Y.; Chen, H.; Shi, J. In vivo bio-Safety evaluations and diagnostic/therapeutic applications
of chemically designed mesoporous silica nanoparticles. Adv. Mater. 2013, 25, 3144–3176.
183. Lin, Y.-S.; Hurley, K.R.; Haynes, C.L. Critical considerations in the biomedical use of
mesoporous silica nanoparticles. J. Phys. Chem. Lett. 2012, 3, 364–374.
184. Rosenholm, J.M.; Mamaeva, V.; Sahlgren, C.; Linden, M. Nanoparticles in targeted cancer
therapy: Mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine
2012, 7, 111–120.
185. Benezra, M.; Penate-Medina, O.; Zanzonico, P.B.; Schaer, D.; Ow, H.; Burns, A.; DeStanchina, E.;
Longo, V.; Herz, E.; Iyer, S.; et al. Multimodal silica nanoparticles are effective cancer-targeted
probes in a model of human melanoma. J. Clin. Investig. 2011, 121, 2768–2780.
186. Jaganathan, H.; Godin, B. Biocompatibility assessment of Si-based nano- and micro-particles.
Adv. Drug Deliv. Rev. 2012, 64, 1800–1819.
187. Slowing, I.I.; Wu, C.-W.; Vivero-Escoto, J.L.; Lin, V.S.-Y. Mesoporous Silica Nanoparticles for
Reducing Hemolytic Activity towards Mammalian Red Blood Cells. Small 2009, 5, 57–62.
188. He, Q.J.; Shi, J.L.; Chen, F.; Zhu, M.; Zhang, L.X. An anticancer drug delivery system based on
surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010, 31, 3335–3346.
189. He, Q.; Zhang, Z.; Gao, F.; Li, Y.; Shi, J. In vivo biodistribution and urinary excretion of
mesoporous silica nanoparticles: Effects of particle size and PEGylation. Small 2011, 7,
271–280.
190. Asefa, T.; Zhimin, T.; Biocompatibility of Mesoporous Silica Nanoparticles. Chem. Res. Toxicol.
2012, 25, 2265–2284.
191. Yu, T.; Greish, K.; McGill, L.D.; Ray, A.; Ghandehari, H. Influence of geometry, porosity, and
surface characteristics of silica nanoparticles on acute toxicity: Their vasculature effect and
tolerance threshold. ACS Nano 2012, 6, 2289–2301.
192. Hudson, S.P.; Padera, R.F.; Langer, R.; Kohane, D.S. The biocompatibility of mesoporous
silicates. Biomaterials 2008, 29, 4045–4055.
193. Liu, T.L.; Li, L.L.; Teng, X.; Huang, X.L.; Liu, H.Y.; Chen, D.; Ren, J.; He, J.Q.; Tang, F.Q.
Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously
exposed mice. Biomaterials 2011, 32, 1657–1668.
194. Fadeel, B.; García-Bennett, A.E. Better safe than sorry: Understanding the toxicological
properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv.
Rev. 2010, 62, 362–374.
195. He, Q.J.; Zhang, J.M.; Shi, J.L.; Zhu, Z.Y.; Zhang, L.X.; Bu, W.B.; Guo, L.M.; Chen , Y. The
effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins
and cellular responses. Biomaterials 2010, 31, 1085–1092.
196. Wu, S.-H.; Lin, Y.-S.; Hung, Y.; Chou, Y.-H.; Hsu, Y.-H.; Chang, C.; Mou, C.-Y.
Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic
resonance imaging studies. Chembiochem 2008, 9, 53–57.
Nanomaterials 2015, 5 1937
197. Lee, C.-H.; Cheng, S.-H.; Wang, Y.; Chen, Y.-C.; Chen, N.-T.; Souris, J.; Chen, C.-T.; Mou, C.-Y.;
Yang, C.-S.; Lo, L.-W. Near-infrared mesoporous silica sanoparticles for optical imaging:
Characterization and in vivo biodistribution. Adv. Funct. Mater. 2009, 19, 215–222.
198. Martin, K.R. The chemistry of silica and its potential health benefits. J. Nutr. Health Aging 2007,
11, 94–98.
199. Mamaeva, V.; Rosenholm, J.M.; Bate-Eya, L.T.; Bergman, L.; Peuhu, E.; Duchanoy, A.;
Fortelius, L.E.; Landor, S.; Toivola, D.M.; Linden, M.; et al. Mesoporous silica nanoparticles as
drug delivery systems for targeted inhibition of notch signaling in cancer. Mol. Ther. 2011, 19,
1538–1546.
200. Szakacs, G.; Paterson, J.K.; Ludwig, J.A.; Booth-Genthe, C.; Gottesman, M.M. Targeting
multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5, 219–234.
201. Nichols, J.W.; Bae, Y.H. Odyssey of a cancer nanoparticle: From injection site to site of action.
Nano Today 2012, 7, 606–618.
202. Mikhail, A.S.; Allen, C. Block copolymer micelles for delivery of cancer therapy: Transport at
the whole body, tissue and cellular levels. J. Controll. Release 2009, 138, 214–223.
203. Wu, S.-H.; Mou, C.-Y.; Lin, H.-P. Synthesis of mesoporous silica nanoparticles. Chem. Soc. Rev.
2013, 42, 3862–3875.